DDD 3D Systems | $2.12
-1.6% | 3/28/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $5.75 -> $5.00 | Medium | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 3/28/2025 |
LCID Lucid Group | $2.32
-4.1% | 3/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 3/28/2025 |
CMPS COMPASS Pathways | $2.94
-4.9% | 3/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 3/28/2025 |
ZLAB Zai Lab | $37.29
+3.1% | 3/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 3/27/2025 |
SLNO Soleno Therapeutics | $71.99
+6.8% | 3/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $67.00 -> $123.00 | High | View details for Cantor Fitzgerald rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/27/2025 |
ACRV Acrivon Therapeutics | $2.24
-11.1% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/26/2025 |
XFOR X4 Pharmaceuticals | $0.25
-7.8% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $3.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/26/2025 |
LUCD Lucid Diagnostics | $1.58
-0.6% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $2.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/26/2025 |
SMTI Sanara MedTech | $30.19
-3.3% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $46.00 -> $46.00 | Medium | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/26/2025 |
ARTV Artiva Biotherapeutics | $3.16
-10.7% | 3/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $23.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/25/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
LUNR Intuitive Machines | $8.07
-2.4% | 3/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $15.00 -> $13.00 | Medium | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/25/2025 |
OUST Ouster | $9.54
-4.4% | 3/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $10.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/21/2025 |
MU Micron Technology | $88.44
-3.0% | 3/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $130.00 -> $130.00 | High | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/21/2025 |
PL Planet Labs PBC | $3.45
-7.2% | 3/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $6.30 -> $6.30 | High | View details for Cantor Fitzgerald rating of Planet Labs PBC (NYSE:PL) on 3/21/2025 |
SMMT Summit Therapeutics | $20.32
-1.4% | 3/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 3/21/2025 |
GLYC GlycoMimetics | $0.22
-10.7% | 3/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of GlycoMimetics (NASDAQ:GLYC) on 3/21/2025 |
ALMS Alumis | $5.64
+20.0% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 3/20/2025 |
DOMO Domo | $7.96
-3.6% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $11.00 | Medium | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 3/20/2025 |
CI The Cigna Group | $324.97
+0.1% | 3/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $350.00 -> $365.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/20/2025 |
CAPR Capricor Therapeutics | $11.50
-2.6% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/20/2025 |
TWI Titan International | $8.60
-4.1% | 3/20/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $11.00 | High | View details for Cantor Fitzgerald rating of Titan International (NYSE:TWI) on 3/20/2025 |
GOOG Alphabet | $156.06
-4.9% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOG) on 3/19/2025 |
NVDA NVIDIA | $109.67
-1.6% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/19/2025 |
GOOGL Alphabet | $154.33
-4.9% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 3/19/2025 |
TSLA Tesla | $263.55
-3.5% | 3/19/2025 | Upgraded by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Overweight | $425.00 -> $425.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 3/19/2025 |
IRON Disc Medicine | $52.36
-0.2% | 3/18/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $99.00 -> $132.00 | Medium | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 3/18/2025 |
BLTE Belite Bio | $66.70
-0.2% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 3/18/2025 |
MREO Mereo BioPharma Group | $2.30
-4.6% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $7.00 -> $7.00 | High | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/18/2025 |
SRPT Sarepta Therapeutics | $70.41
-1.9% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $163.00 -> $163.00 | High | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/18/2025 |
ACRS Aclaris Therapeutics | $1.59
-1.9% | 3/18/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 3/18/2025 |
RBRK Rubrik | $63.65
-3.6% | 3/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $85.00 -> $85.00 | High | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 3/14/2025 |
EVEX EVE | $3.50
-1.5% | 3/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | High | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 3/14/2025 |
NVMI Nova | $186.43
-3.3% | 3/14/2025 | Target Lowered by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $315.00 -> $300.00 | Low | View details for Cantor Fitzgerald rating of Nova (NASDAQ:NVMI) on 3/14/2025 |
TARA Protara Therapeutics | $4.58
+0.9% | 3/14/2025 | Initiated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight | | Low | View details for Cantor Fitzgerald rating of Protara Therapeutics (NASDAQ:TARA) on 3/14/2025 |
BCAX Bicara Therapeutics | $13.40
| 3/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $13.01 -> $13.01 | Medium | View details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 3/13/2025 |
S SentinelOne | $18.84
-2.7% | 3/13/2025 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $30.00 -> $24.00 | High | View details for Cantor Fitzgerald rating of SentinelOne (NYSE:S) on 3/13/2025 |
ZVRA Zevra Therapeutics | $7.85
-1.4% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/12/2025 |
TER Teradyne | $82.78
-3.4% | 3/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $150.00 -> $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/12/2025 |
BEAM Beam Therapeutics | $22.21
+0.1% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst R. Bienkowski | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 3/12/2025 |
VYGR Voyager Therapeutics | $3.65
-2.4% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/12/2025 |
Trump’s betrayal exposed (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
ORCL Oracle | $140.75
-3.5% | 3/11/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $214.00 -> $175.00 | High | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 3/11/2025 |
NOW ServiceNow | $796.61
-3.8% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 3/11/2025 |
LFMD LifeMD | $5.45
-2.7% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $15.00 -> $15.00 | High | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 3/11/2025 |
TBRG TruBridge | $28.11
-1.5% | 3/11/2025 | Target Raised by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $20.00 -> $29.00 | High | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/11/2025 |
RDW Redwire | $8.81
-10.7% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $28.00 -> $28.00 | Medium | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 3/11/2025 |
HIVE HIVE Digital Technologies | $1.50
-6.8% | 3/11/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $10.00 -> $8.00 | Medium | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 3/11/2025 |
AARD Aardvark Therapeutics | $7.74
-13.0% | 3/10/2025 | Initiated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight | $50.00 | High | View details for Cantor Fitzgerald rating of Aardvark Therapeutics (NASDAQ:AARD) on 3/10/2025 |
WDC Western Digital | $40.62
-3.1% | 3/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 3/7/2025 |
ADCT ADC Therapeutics | $1.49
-2.3% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of ADC Therapeutics (NYSE:ADCT) on 3/7/2025 |
ARCT Arcturus Therapeutics | $11.58
-3.5% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Pete Stavropoulos | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/7/2025 |
AVGO Broadcom | $169.12
-1.7% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $300.00 -> $300.00 | High | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/7/2025 |
ELUT Elutia | $2.64
-0.8% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $8.00 -> $8.00 | High | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 3/7/2025 |
DOMO Domo | $7.96
-3.6% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 3/7/2025 |
BBAI BigBear.ai | $3.05
-0.5% | 3/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $8.00 -> $6.00 | Medium | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/7/2025 |
HUT Hut 8 | $11.72
-5.9% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 3/7/2025 |
HOOD Robinhood Markets | $41.92
-4.7% | 3/6/2025 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $69.00 | High | View details for Cantor Fitzgerald rating of Robinhood Markets (NASDAQ:HOOD) on 3/6/2025 |
NPCE NeuroPace | $11.85
-4.3% | 3/5/2025 | Target Raised by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $19.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/5/2025 |
AXGN AxoGen | $18.36
-3.3% | 3/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $24.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of AxoGen (NASDAQ:AXGN) on 3/5/2025 |
EVGO EVgo | $2.82
-2.8% | 3/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $8.00 -> $8.00 | High | View details for Cantor Fitzgerald rating of EVgo (NASDAQ:EVGO) on 3/5/2025 |
CRWD CrowdStrike | $357.11
-2.6% | 3/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $440.00 -> $440.00 | High | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2025 |
ZLAB Zai Lab | $37.29
+3.1% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 3/4/2025 |
MDB MongoDB | $178.03
-5.6% | 3/5/2025 | Initiated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight | $344.00 | High | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 3/5/2025 |
GAMB Gambling.com Group | $12.67
-5.1% | 3/5/2025 | Initiated by | Cantor Fitzgerald | Analyst E. James | Overweight | $20.00 | High | View details for Cantor Fitzgerald rating of Gambling.com Group (NASDAQ:GAMB) on 3/5/2025 |
ROIV Roivant Sciences | $10.38
-1.0% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 3/4/2025 |
MESO Mesoblast | $12.11
-8.9% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 3/4/2025 |
KURA Kura Oncology | $7.05
-1.3% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 3/4/2025 |
IMVT Immunovant | $18.37
-2.2% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 3/4/2025 |
CATX Perspective Therapeutics | $2.20
-4.3% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 3/4/2025 |
ARDX Ardelyx | $4.93
-4.1% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 3/4/2025 |
ACRS Aclaris Therapeutics | $1.59
-1.9% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 3/4/2025 |
ASTS AST SpaceMobile | $24.06
-6.7% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of AST SpaceMobile (NASDAQ:ASTS) on 3/4/2025 |
SSYS Stratasys | $10.11
-1.7% | 3/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $12.00 -> $15.00 | High | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 3/4/2025 |
ADMA ADMA Biologics | $20.26
-0.1% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 3/4/2025 |
GTLB GitLab | $48.38
-3.6% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $80.00 -> $80.00 | High | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/4/2025 |
PLRX Pliant Therapeutics | $1.47
-2.6% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst Pete Stavropoulos | Neutral | | High | View details for Cantor Fitzgerald rating of Pliant Therapeutics (NASDAQ:PLRX) on 3/4/2025 |
PI Impinj | $91.80
-1.1% | 2/27/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Jensen | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 2/27/2025 |
KRNT Kornit Digital | $19.50
-2.9% | 2/27/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Jensen | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 2/27/2025 |
CORZ Core Scientific | $7.48
-5.1% | 2/27/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $24.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Core Scientific (NASDAQ:CORZ) on 2/27/2025 |
MDXG MiMedx Group | $7.54
-2.6% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $13.00 -> $13.00 | High | View details for Cantor Fitzgerald rating of MiMedx Group (NASDAQ:MDXG) on 2/27/2025 |
JOBY Joby Aviation | $6.12
-4.8% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $9.00 -> $9.00 | High | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 2/27/2025 |
ACAD ACADIA Pharmaceuticals | $17.07
-0.7% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | $28.00 -> $28.00 | High | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/27/2025 |
EBAY eBay | $67.16
+0.5% | 2/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $65.00 -> $70.00 | Medium | View details for Cantor Fitzgerald rating of eBay (NASDAQ:EBAY) on 2/27/2025 |
SNOW Snowflake | $150.60
-4.1% | 2/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $201.00 -> $228.00 | High | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 2/27/2025 |
NVDA NVIDIA | $109.67
-1.6% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 2/27/2025 |
JAZZ Jazz Pharmaceuticals | $122.92
-2.8% | 2/26/2025 | Downgraded by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Neutral | $140.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/26/2025 |
XMTR Xometry | $25.89
-2.7% | 2/26/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Underweight -> Underweight | $12.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 2/26/2025 |
DOCN DigitalOcean | $34.17
-3.8% | 2/26/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $39.00 -> $43.00 | High | View details for Cantor Fitzgerald rating of DigitalOcean (NYSE:DOCN) on 2/26/2025 |
LCID Lucid Group | $2.32
-4.1% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 2/26/2025 |
CART Maplebear | $39.73
-1.9% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $55.00 -> $55.00 | High | View details for Cantor Fitzgerald rating of Maplebear (NASDAQ:CART) on 2/26/2025 |
SUPN Supernus Pharmaceuticals | $32.29
-0.4% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Neutral -> Neutral | $36.00 -> $36.00 | High | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 2/26/2025 |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
RARE Ultragenyx Pharmaceutical | $37.82
-2.8% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $118.00 -> $118.00 | Medium | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/26/2025 |
SSTI SoundThinking | $17.44
-5.8% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $20.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/26/2025 |
SAIC Science Applications International | $112.53
+1.1% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/25/2025 |
PHAT Phathom Pharmaceuticals | $6.60
-1.3% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 2/25/2025 |
LDOS Leidos | $133.95
-1.3% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/25/2025 |
DOMO Domo | $7.96
-3.6% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst Y. Lee | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 2/25/2025 |
CACI CACI International | $373.55
-0.6% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/25/2025 |
BAH Booz Allen Hamilton | $105.30
-0.5% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/25/2025 |
ASTS AST SpaceMobile | $24.06
-6.7% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of AST SpaceMobile (NASDAQ:ASTS) on 2/25/2025 |
AMTM Amentum | $18.04
-1.9% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Amentum (NYSE:AMTM) on 2/25/2025 |
MTSR Metsera | $28.00
-6.7% | 2/25/2025 | Initiated by | Cantor Fitzgerald | Analyst Prakhar Agrawal | Overweight | | High | View details for Cantor Fitzgerald rating of Metsera (NASDAQ:MTSR) on 2/25/2025 |
ASND Ascendis Pharma A/S | $154.68
-2.1% | 2/25/2025 | Target Raised by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $170.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/25/2025 |
ZM Zoom Video Communications | $74.84
-2.5% | 2/25/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $87.00 -> $87.00 | High | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 2/25/2025 |
RIOT Riot Platforms | $7.41
-4.6% | 2/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $23.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 2/25/2025 |
SIBN SI-BONE | $14.04
+0.4% | 2/25/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 2/25/2025 |
SOUN SoundHound AI | $8.50
-4.3% | 2/24/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 2/24/2025 |
ORCL Oracle | $140.75
-3.5% | 2/10/2025 | Downgraded by | Cantor Fitzgerald | Analyst T. Blakey | Overweight | | Medium | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 2/10/2025 |
MELI MercadoLibre | $2,048.07
-2.3% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,150.00 -> $3,000.00 | High | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 2/21/2025 |
FIVN Five9 | $27.75
-5.4% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $46.00 -> $57.00 | High | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 2/21/2025 |
SABR Sabre | $3.06
-6.4% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 2/21/2025 |
BKNG Booking | $4,634.24
-2.5% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $4,900.00 -> $5,540.00 | High | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 2/21/2025 |
BBIO BridgeBio Pharma | $35.11
-3.5% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $95.00 -> $95.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 2/21/2025 |
TVTX Travere Therapeutics | $19.68
-3.4% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 2/21/2025 |
CERS Cerus | $1.42
-1.4% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $4.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 2/21/2025 |
PRTA Prothena | $13.14
+1.0% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 2/21/2025 |
TRIP Tripadvisor | $14.09
-4.0% | 2/21/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $14.00 -> $13.00 | High | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 2/21/2025 |
NICE NICE | $155.48
-2.1% | 2/21/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $176.00 -> $161.00 | Low | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 2/21/2025 |
RIVN Rivian Automotive | $12.41
-4.7% | 2/21/2025 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $13.00 -> $15.00 | Medium | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 2/21/2025 |
KRYS Krystal Biotech | $183.92
+0.6% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $215.00 | High | View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 2/20/2025 |
WIX Wix.com | $166.36
-4.3% | 2/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $260.00 -> $270.00 | High | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 2/20/2025 |
ETSY Etsy | $46.69
-0.5% | 2/20/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $46.00 -> $43.00 | Medium | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 2/20/2025 |
ENVX Enovix | $7.48
-6.6% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 2/20/2025 |
KVYO Klaviyo | $30.95
-5.9% | 2/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $47.00 -> $54.00 | High | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 2/20/2025 |
BMRN BioMarin Pharmaceutical | $71.44
-1.9% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $90.00 -> $90.00 | High | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/20/2025 |
AXSM Axsome Therapeutics | $118.53
-2.7% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | $153.00 -> $153.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/19/2025 |
INSM Insmed | $77.99
+0.4% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Insmed (NASDAQ:INSM) on 2/19/2025 |
CRSP CRISPR Therapeutics | $36.99
-2.8% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Neutral -> Neutral | | Medium | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/19/2025 |
CNCK Coincheck Group | $5.16
-5.0% | 2/19/2025 | Initiated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight | $10.00 | Medium | View details for Cantor Fitzgerald rating of Coincheck Group (NASDAQ:CNCK) on 2/19/2025 |
SUPN Supernus Pharmaceuticals | $32.29
-0.4% | 2/19/2025 | Downgraded by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Neutral | $57.00 -> $36.00 | High | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 2/19/2025 |
LRCX Lam Research | $72.61
-2.9% | 2/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/18/2025 |
WDC Western Digital | $40.62
-3.1% | 2/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 2/18/2025 |
INTC Intel | $22.71
-3.9% | 2/18/2025 | Target Raised by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $22.00 -> $29.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 2/18/2025 |
PHAT Phathom Pharmaceuticals | $6.60
-1.3% | 2/14/2025 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $23.00 | High | View details for Cantor Fitzgerald rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 2/14/2025 |
MKSI MKS Instruments | $81.59
-3.8% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $140.00 -> $140.00 | High | View details for Cantor Fitzgerald rating of MKS Instruments (NASDAQ:MKSI) on 2/13/2025 |
KRNT Kornit Digital | $19.50
-2.9% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $39.00 -> $39.00 | Low | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 2/13/2025 |
IREN Iris Energy | $6.07
-6.0% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $23.00 -> $23.00 | High | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 2/13/2025 |
THC Tenet Healthcare | $133.17
-0.9% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $177.00 -> $177.00 | High | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 2/13/2025 |
AUR Aurora Innovation | $6.68
-10.5% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 2/13/2025 |
TTD Trade Desk | $55.85
-2.5% | 2/13/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $115.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Trade Desk (NASDAQ:TTD) on 2/13/2025 |
GHRS GH Research | $11.06
-9.7% | 2/13/2025 | Initiated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of GH Research (NASDAQ:GHRS) on 2/13/2025 |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
CVS CVS Health | $67.13
-0.7% | 2/12/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. James | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 2/12/2025 |
HUM Humana | $263.95
-2.4% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Neutral -> Neutral | $290.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 2/12/2025 |
DASH DoorDash | $182.61
-5.9% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $230.00 | Medium | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 2/12/2025 |
ZG Zillow Group | $67.20
-2.3% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $62.00 -> $70.00 | Medium | View details for Cantor Fitzgerald rating of Zillow Group (NASDAQ:ZG) on 2/12/2025 |
LYFT Lyft | $11.57
-4.7% | 2/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $15.00 -> $14.00 | High | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 2/12/2025 |
FRSH Freshworks | $14.53
-4.2% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $18.00 -> $22.00 | High | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 2/12/2025 |
FROG JFrog | $32.00
-1.1% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $38.00 -> $38.00 | High | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 2/12/2025 |
PANW Palo Alto Networks | $172.76
-1.0% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $223.00 -> $223.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/12/2025 |
SHOP Shopify | $96.51
-5.9% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $120.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 2/12/2025 |
ASND Ascendis Pharma A/S | $154.68
-2.1% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $170.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/11/2025 |
MNDY monday.com | $247.01
-3.4% | 2/11/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $292.00 -> $380.00 | Low | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 2/11/2025 |
VRTX Vertex Pharmaceuticals | $492.69
-2.0% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/11/2025 |
SEPN Septerna | $6.10
-3.0% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $50.00 -> $50.00 | High | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 2/11/2025 |
DOMO Domo | $7.96
-3.6% | 2/11/2025 | Initiated by | Cantor Fitzgerald | Analyst Yi Fu Lee | Overweight | $11.00 | Medium | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 2/11/2025 |
WDC Western Digital | $40.62
-3.1% | 2/10/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 2/10/2025 |
PRLB Proto Labs | $35.78
-3.4% | 2/10/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $40.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 2/10/2025 |
SAIC Science Applications International | $112.53
+1.1% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/6/2025 |
LDOS Leidos | $133.95
-1.3% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/6/2025 |
CACI CACI International | $373.55
-0.6% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/6/2025 |
BAH Booz Allen Hamilton | $105.30
-0.5% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/6/2025 |
ARVN Arvinas | $7.59
-5.6% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Arvinas (NASDAQ:ARVN) on 2/7/2025 |
PINS Pinterest | $31.49
-2.3% | 2/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $36.00 -> $48.00 | High | View details for Cantor Fitzgerald rating of Pinterest (NYSE:PINS) on 2/7/2025 |
AMZN Amazon.com | $192.72
-4.3% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 2/7/2025 |
EXPE Expedia Group | $168.10
-0.6% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $180.00 -> $210.00 | High | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 2/7/2025 |
NET Cloudflare | $114.89
-3.1% | 2/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $111.00 -> $149.00 | High | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 2/7/2025 |
ONTO Onto Innovation | $121.99
-5.0% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Onto Innovation (NYSE:ONTO) on 2/7/2025 |
CACI CACI International | $373.55
-0.6% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $535.00 | Low | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/7/2025 |
BAH Booz Allen Hamilton | $105.30
-0.5% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/7/2025 |
AMTM Amentum | $18.04
-1.9% | 2/7/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy -> Neutral | $25.00 | Medium | View details for Cantor Fitzgerald rating of Amentum (NYSE:AMTM) on 2/7/2025 |
SAIC Science Applications International | $112.53
+1.1% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Neutral | $120.00 | Medium | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/7/2025 |
LDOS Leidos | $133.95
-1.3% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $185.00 | Medium | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/7/2025 |
MSTR MicroStrategy | $289.41
-10.8% | 2/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $613.00 -> $619.00 | High | View details for Cantor Fitzgerald rating of MicroStrategy (NASDAQ:MSTR) on 2/6/2025 |
PI Impinj | $91.80
-1.1% | 2/6/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $260.00 -> $133.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 2/6/2025 |
DT Dynatrace | $48.39
-1.3% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $57.00 -> $57.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 2/6/2025 |
UBER Uber Technologies | $72.71
-2.9% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $80.00 -> $80.00 | High | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 2/6/2025 |
QCOM QUALCOMM | $152.72
-3.3% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $160.00 -> $160.00 | High | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 2/6/2025 |
CSGS CSG Systems International | $59.53
-2.2% | 2/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $64.00 -> $72.00 | High | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 2/6/2025 |
SYM Symbotic | $20.16
-6.3% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $60.00 -> $60.00 | High | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 2/6/2025 |
ASTS AST SpaceMobile | $24.06
-6.7% | 2/6/2025 | Initiated by | Cantor Fitzgerald | Analyst Colin Canfield | Overweight | $30.00 | High | View details for Cantor Fitzgerald rating of AST SpaceMobile (NASDAQ:ASTS) on 2/6/2025 |
ZLAB Zai Lab | $37.29
+3.1% | 2/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 2/5/2025 |
CDTX Cidara Therapeutics | $22.39
+3.8% | 2/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst E. Schmidt | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 2/5/2025 |
CATX Perspective Therapeutics | $2.20
-4.3% | 2/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 2/5/2025 |
CIFR Cipher Mining | $2.32
-8.7% | 2/4/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $11.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 2/4/2025 |
NXPI NXP Semiconductors | $189.99
-5.0% | 2/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $250.00 -> $250.00 | High | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/4/2025 |
BMY Bristol-Myers Squibb | $60.10
+2.0% | 2/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst Olivia Brayer | Neutral -> Neutral | $50.00 -> $55.00 | Medium | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 2/4/2025 |
FTNT Fortinet | $96.60
-3.0% | 2/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $95.00 -> $110.00 | Medium | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 2/4/2025 |
PLTR Palantir Technologies | $85.85
-4.7% | 2/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $72.00 -> $98.00 | N/A | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 2/4/2025 |
UHS Universal Health Services | $186.11
-0.2% | 2/3/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. James | Neutral -> Overweight | | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 2/3/2025 |
PTCT PTC Therapeutics | $54.24
-1.4% | 2/3/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $76.00 -> $113.00 | High | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 2/3/2025 |
SSYS Stratasys | $10.11
-1.7% | 2/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $12.00 -> $12.00 | High | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 2/3/2025 |
Trump’s betrayal exposed (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
ROIV Roivant Sciences | $10.38
-1.0% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 1/30/2025 |
MESO Mesoblast | $12.11
-8.9% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 1/30/2025 |
IMVT Immunovant | $18.37
-2.2% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 1/30/2025 |
ARDX Ardelyx | $4.93
-4.1% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 1/30/2025 |
ACRS Aclaris Therapeutics | $1.59
-1.9% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/30/2025 |
KLAC KLA | $673.60
-3.8% | 1/31/2025 | Target Raised by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $800.00 -> $875.00 | High | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 1/31/2025 |
INTC Intel | $22.71
-3.9% | 1/31/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $22.00 -> $22.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 1/31/2025 |
VRTX Vertex Pharmaceuticals | $492.69
-2.0% | 1/31/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/31/2025 |
CI The Cigna Group | $324.97
+0.1% | 1/31/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $400.00 -> $350.00 | Medium | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 1/31/2025 |
DT Dynatrace | $48.39
-1.3% | 1/31/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $58.00 -> $57.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 1/31/2025 |
ACRV Acrivon Therapeutics | $2.24
-11.1% | 1/31/2025 | Initiated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight | | Low | View details for Cantor Fitzgerald rating of Acrivon Therapeutics (NASDAQ:ACRV) on 1/31/2025 |
TEAM Atlassian | $217.99
-2.1% | 1/31/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $264.00 -> $304.00 | High | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/31/2025 |
TER Teradyne | $82.78
-3.4% | 1/30/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $160.00 -> $160.00 | High | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 1/30/2025 |
META Meta Platforms | $576.74
-4.3% | 1/30/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $720.00 -> $790.00 | High | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 1/30/2025 |
WDC Western Digital | $40.62
-3.1% | 1/30/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 1/30/2025 |
ZVRA Zevra Therapeutics | $7.85
-1.4% | 1/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 1/29/2025 |
LRCX Lam Research | $72.61
-2.9% | 1/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Overweight | $95.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 1/30/2025 |
CVLT Commvault Systems | $161.98
-2.0% | 1/29/2025 | Target Raised by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral -> Neutral | $159.00 -> $173.00 | High | View details for Cantor Fitzgerald rating of Commvault Systems (NASDAQ:CVLT) on 1/29/2025 |
TSLA Tesla | $263.55
-3.5% | 1/29/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $365.00 -> $365.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 1/29/2025 |
CLDX Celldex Therapeutics | $19.93
-0.3% | 1/29/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $67.00 -> $67.00 | High | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 1/29/2025 |
MSFT Microsoft | $378.80
-3.0% | 1/29/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $509.00 -> $509.00 | Low | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/29/2025 |
BKNG Booking | $4,634.24
-2.5% | 1/29/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $5,100.00 -> $4,900.00 | Low | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 1/29/2025 |
EXPE Expedia Group | $168.10
-0.6% | 1/29/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 1/29/2025 |
BEAM Beam Therapeutics | $22.21
+0.1% | 1/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst R. Bienkowski | Neutral -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 1/29/2025 |
UBER Uber Technologies | $72.71
-2.9% | 1/28/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $75.00 -> $80.00 | Medium | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 1/28/2025 |
DASH DoorDash | $182.61
-5.9% | 1/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 1/28/2025 |
SPOT Spotify Technology | $559.76
-3.5% | 1/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $490.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 1/28/2025 |
CDTX Cidara Therapeutics | $22.39
+3.8% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Medium | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 1/27/2025 |
CYBR CyberArk Software | $335.74
-1.6% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $415.00 -> $415.00 | High | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 1/27/2025 |
CHKP Check Point Software Technologies | $228.37
-1.3% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $200.00 -> $200.00 | High | View details for Cantor Fitzgerald rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/27/2025 |
NVDA NVIDIA | $109.67
-1.6% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst C J Muse | Overweight -> Overweight | $200.00 -> $200.00 | High | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 1/27/2025 |
HCA HCA Healthcare | $342.25
0.0% | 1/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $405.00 -> $405.00 | High | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 1/27/2025 |
TXN Texas Instruments | $176.33
-2.5% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jonathan Fiore | Neutral -> Neutral | $200.00 -> $200.00 | High | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 1/24/2025 |
ALXO ALX Oncology | $0.66
-8.3% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 1/24/2025 |
ELV Elevance Health | $431.84
0.0% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $485.00 -> $485.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 1/24/2025 |
VRTX Vertex Pharmaceuticals | $492.69
-2.0% | 1/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/24/2025 |
ZLDPF Zealand Pharma A/S | $76.10
| 1/21/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 1/21/2025 |
RDW Redwire | $8.81
-10.7% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst Colin Canfield | Overweight -> Overweight | $28.00 -> $28.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 1/24/2025 |
VSAT Viasat | $10.92
-4.8% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Neutral | $12.00 | Medium | View details for Cantor Fitzgerald rating of Viasat (NASDAQ:VSAT) on 1/24/2025 |
PL Planet Labs PBC | $3.45
-7.2% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight | $6.30 | High | View details for Cantor Fitzgerald rating of Planet Labs PBC (NYSE:PL) on 1/24/2025 |
IRDM Iridium Communications | $27.54
-6.6% | 1/24/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight | $40.00 | High | View details for Cantor Fitzgerald rating of Iridium Communications (NASDAQ:IRDM) on 1/24/2025 |
SYM Symbotic | $20.16
-6.3% | 1/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $60.00 -> $60.00 | Low | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 1/23/2025 |
AMZN Amazon.com | $192.72
-4.3% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 1/22/2025 |
STX Seagate Technology | $84.92
-2.9% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $120.00 -> $120.00 | High | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 1/22/2025 |
RARE Ultragenyx Pharmaceutical | $37.82
-2.8% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $118.00 -> $118.00 | Medium | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/22/2025 |
SMTI Sanara MedTech | $30.19
-3.3% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $44.00 -> $44.00 | High | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 1/22/2025 |
META Meta Platforms | $576.74
-4.3% | 1/22/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $730.00 -> $720.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 1/22/2025 |
GOOGL Alphabet | $154.33
-4.9% | 1/22/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $215.00 -> $210.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 1/22/2025 |
KROS Keros Therapeutics | $10.79
-1.8% | 1/21/2025 | Downgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 1/21/2025 |
AMPX Amprius Technologies | $2.80
-5.3% | 1/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of Amprius Technologies (NYSE:AMPX) on 1/21/2025 |
ZM Zoom Video Communications | $74.84
-2.5% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $87.00 | N/A | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 1/16/2025 |
TEAM Atlassian | $217.99
-2.1% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $264.00 | N/A | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/16/2025 |
SNOW Snowflake | $150.60
-4.1% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $201.00 | N/A | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 1/16/2025 |
PLTR Palantir Technologies | $85.85
-4.7% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $72.00 | N/A | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 1/16/2025 |
ORCL Oracle | $140.75
-3.5% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $214.00 | N/A | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 1/16/2025 |
NOW ServiceNow | $796.61
-3.8% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $1,332.00 | N/A | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 1/16/2025 |
NICE NICE | $155.48
-2.1% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $176.00 | N/A | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 1/16/2025 |
MSFT Microsoft | $378.80
-3.0% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $509.00 | N/A | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/16/2025 |
MNDY monday.com | $247.01
-3.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $292.00 | N/A | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 1/16/2025 |
MDB MongoDB | $178.03
-5.6% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $344.00 | N/A | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 1/16/2025 |
